>The technology was fine, the salesmanship wasn't.<
I recall their making some astonishingly lofty claim about genomics, proteomics, or some other omics during the bubble days—something to the effect that they had the key to the only efficient way of developing protein drugs. Hence I presume you are not talking about that technology.
What ever became of the tobacco-based cancer vaccine?
Market Data 
Markets 
